Dexcom Profit Margin

The latest profit margin for DXCM is 20.12% as of June 2026. That compares with 13.29% in the prior-year period — up 51.4% year over year. That is above the Healthcare sector average of 15.29%. Investors often review this figure alongside Dexcom's historical trend and sector peers before judging valuation or financial health.

Over the past year, DXCM's profit margin moved from 13.29% to 20.12% — a 51.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dexcom's valuation or profitability profile.

Against Healthcare companies, DXCM currently prints 20.12% for profit margin, while the sector average sits near 15.29%. That is roughly 31.6% above the sector mean. Large gaps often invite a closer look at Dexcom's growth, margins, and balance sheet.

Profit Margin shows how effectively Dexcom converts resources into returns. At 20.12%, DXCM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.29% in the prior-year period — up 51.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DXCM's profit margin (20.12%), review year-over-year change from 13.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.